GB0809776D0 - Compounds - Google Patents

Compounds

Info

Publication number: GB0809776D0
Authority: GB; United Kingdom
Prior art keywords: compounds
Prior art date: 2008-05-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0809776.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Amura Therapeutics Ltd

Original Assignee

Amura Therapeutics Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-05-29

Filing date

2008-05-29

Publication date

2008-07-09

2008-05-29 Application filed by Amura Therapeutics Ltd filed Critical Amura Therapeutics Ltd

2008-05-29 Priority to GBGB0809776.8A priority Critical patent/GB0809776D0/en

2008-07-09 Publication of GB0809776D0 publication Critical patent/GB0809776D0/en

2009-05-28 Priority to PCT/GB2009/001319 priority patent/WO2009144450A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

GBGB0809776.8A 2008-05-29 2008-05-29 Compounds Ceased GB0809776D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB0809776.8A GB0809776D0 (en)	2008-05-29	2008-05-29	Compounds
PCT/GB2009/001319 WO2009144450A1 (en)	2008-05-29	2009-05-28	Tetrahydrofuro [3, 2-b] pyrrol-3-one derivatives as inhibitors of cysteine proteases

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0809776.8A GB0809776D0 (en)	2008-05-29	2008-05-29	Compounds

Publications (1)

Publication Number	Publication Date
GB0809776D0 true GB0809776D0 (en)	2008-07-09

Family

ID=39637797

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0809776.8A Ceased GB0809776D0 (en)	2008-05-29	2008-05-29	Compounds

Country Status (2)

Country	Link
GB (1)	GB0809776D0 (en)
WO (1)	WO2009144450A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2388262A1 (en) *	2010-05-20	2011-11-23	Stichting Dutch Polymer Institute	New biobased chiral compounds
LT3102576T (en)	2014-02-03	2019-08-12	Vitae Pharmaceuticals, Llc	Dihydropyrrolopyridine inhibitors of ror-gamma
EA031967B1 (en)	2014-10-14	2019-03-29	Вайтаи Фармасьютиклз, Инк.	Dihydropyrrolopyridine inhibitors of ror-gamma
US9663515B2 (en)	2014-11-05	2017-05-30	Vitae Pharmaceuticals, Inc.	Dihydropyrrolopyridine inhibitors of ROR-gamma
US9845308B2 (en)	2014-11-05	2017-12-19	Vitae Pharmaceuticals, Inc.	Isoindoline inhibitors of ROR-gamma
DK3331876T3 (en)	2015-08-05	2021-01-11	Vitae Pharmaceuticals Llc	MODULATORS OF ROR-GAMMA
MX385332B (en)	2015-11-20	2025-03-18	Vitae Pharmaceuticals Llc	ROR-GAMMA MODULATORS.
TW202220968A (en)	2016-01-29	2022-06-01	美商維它藥物有限責任公司	Modulators of ror-gamma
US9481674B1 (en)	2016-06-10	2016-11-01	Vitae Pharmaceuticals, Inc.	Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2019018975A1 (en)	2017-07-24	2019-01-31	Vitae Pharmaceuticals, Inc.	Inhibitors of ror gamma
UA126583C2 (en)	2017-07-24	2022-11-02	Вітае Фармасьютікалс, Ллс	INHIBITORS OF ROR<font face="Symbol">g</font>
EP3946332A1 (en)	2019-04-05	2022-02-09	Université de Bretagne Occidentale	Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning
KR102638391B1 (en) *	2023-05-30	2024-02-20	삼화페인트공업주식회사	Method for producing dialkanesulfonyl isosorbide compound, electrolyte additive for lithium secondary battery, electrolyte for lithium secondary battery, and lithium secondary battery

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0614052D0 (en) *	2006-07-14	2006-08-23	Amura Therapeutics Ltd	Compounds
GB0614042D0 (en) *	2006-07-14	2006-08-23	Amura Therapeutics Ltd	Compounds

2008
- 2008-05-29 GB GBGB0809776.8A patent/GB0809776D0/en not_active Ceased
2009
- 2009-05-28 WO PCT/GB2009/001319 patent/WO2009144450A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2009144450A1 (en)	2009-12-03

Publication	Publication Date	Title
GB0807862D0 (en)	2008-06-04	Compounds
GB0812648D0 (en)	2008-08-20	Compounds
GB0812649D0 (en)	2008-08-20	Compounds
GB0812641D0 (en)	2008-08-20	Compounds
GB0804702D0 (en)	2008-04-16	Compounds
GB0809776D0 (en)	2008-07-09	Compounds
GB0807103D0 (en)	2008-05-21	Compounds
GB0800367D0 (en)	2008-02-20	Compounds
GB0807910D0 (en)	2008-06-04	Compounds
GB0801220D0 (en)	2008-02-27	Compounds
GB0801265D0 (en)	2008-02-27	Compounds
GB0806083D0 (en)	2008-05-14	Compounds
GB0802191D0 (en)	2008-03-12	Compounds
GB0802587D0 (en)	2008-03-19	Compounds
GB0803493D0 (en)	2008-04-02	Compounds
GB0803496D0 (en)	2008-04-02	Compounds
GB0804064D0 (en)	2008-04-09	Compounds
GB0812622D0 (en)	2008-08-20	Compounds
GB0805048D0 (en)	2008-04-16	Niovel compounds
GB0805311D0 (en)	2008-04-30	Compounds
GB0805498D0 (en)	2008-04-30	Compounds
GB0805504D0 (en)	2008-04-30	Compounds
GB0805815D0 (en)	2008-04-30	Compounds
GB0805993D0 (en)	2008-05-07	Compounds
GB0811449D0 (en)	2008-07-30	Compounds

Legal Events

Date	Code	Title	Description
2010-09-15	AT	Applications terminated before publication under section 16(1)